Celsion Corp (CLSN.O)

CLSN.O on Consolidated Issue listed on NASDAQ Capital Market

3.39USD
25 Jul 2014
Price Change (% chg)

$-0.01 (-0.29%)
Prev Close
$3.40
Open
$3.40
Day's High
$3.43
Day's Low
$3.28
Volume
187,381
Avg. Vol
144,869
52-wk High
$6.61
52-wk Low
$2.82

CLSN.O

Chart for CLSN.O

About

Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer. As of December 31, 2011, the Company's product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the HEAT study), a Phase II clinical... (more)

Overall

Beta: 1.75
Market Cap (Mil.): $58.37
Shares Outstanding (Mil.): 17.22
Dividend: --
Yield (%): --

Financials

  CLSN.O Industry Sector
P/E (TTM): -- 106.36 36.09
EPS (TTM): -1.86 -- --
ROI: -29.02 -0.18 18.19
ROE: -35.75 -1.06 19.06
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks